BioMarin Pharmaceutical
BioMarin Pharmaceutical develops and delivers therapies for rare genetic and metabolic conditions. The company applies scientific research to understand the underlying causes of diseases and creates medicines using multiple treatment approaches.Its portfolio includes therapies for achondroplasia, severe hemophilia A, and various lysosomal storage disorders. BioMarin conducts clinical and preclinical research to expand its pipeline of investigational treatments. The company emphasizes collaboration with patient communities to inform therapy development and focuses on translating genetic discoveries into potential new medicines. Its operations encompass research, development, and manufacturing of specialized therapies for complex conditions.
Domain
biomarin.com
Country
United StatesIndustry
BiotechnologyEmployees
1001-5000
Last Funding
$3650.0M
Founded
1997
Tech Stack (24 technologies)
Frequently Asked Questions
What technologies does BioMarin Pharmaceutical use?+
BioMarin Pharmaceutical uses 24 technologies including Google Analytics, Google Tag Manager, OneTrust.
What industry is BioMarin Pharmaceutical in?+
BioMarin Pharmaceutical operates in the Biotechnology industry.
Where is BioMarin Pharmaceutical based?+
BioMarin Pharmaceutical is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026